These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 29130266)
1. School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program. Basurto-Dávila R; Meltzer MI; Mills DA; Beeler Asay GR; Cho BH; Graitcer SB; Dube NL; Thompson MG; Patel SA; Peasah SK; Ferdinands JM; Gargiullo P; Messonnier M; Shay DK Health Serv Res; 2017 Dec; 52 Suppl 2(Suppl 2):2307-2330. PubMed ID: 29130266 [TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial. Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461 [TBL] [Abstract][Full Text] [Related]
3. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial. Schmier J; Li S; King JC; Nichol K; Mahadevia PJ Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department. Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729 [TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of the vaccination program against seasonal and pandemic A/H1N1 influenza among customs officers in Greece. Mamma M; Spandidos DA Health Policy; 2013 Jan; 109(1):71-7. PubMed ID: 23195436 [TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany. Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456 [TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands. de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149 [TBL] [Abstract][Full Text] [Related]
10. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes. de Boer PT; Backer JA; van Hoek AJ; Wallinga J BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789 [TBL] [Abstract][Full Text] [Related]
11. Public health and economic benefits of new pediatric influenza vaccination programs in Argentina. Giglio N; Gentile A; Lees L; Micone P; Armoni J; Reygrobellet C; Crépey P Hum Vaccin Immunother; 2012 Mar; 8(3):312-22. PubMed ID: 22330959 [TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of school-located influenza vaccination programs for elementary and secondary school children. Yoo BK; Schaffer SJ; Humiston SG; Rand CM; Goldstein NPN; Albertin CS; Concannon C; Szilagyi PG BMC Health Serv Res; 2019 Jun; 19(1):407. PubMed ID: 31234842 [TBL] [Abstract][Full Text] [Related]
13. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old. Raj SM; Chughtai AA; Sharma A; Tan TC; MacIntyre CR Vaccine; 2019 Sep; 37(40):5979-5985. PubMed ID: 31473001 [TBL] [Abstract][Full Text] [Related]
15. Economic evaluations of childhood influenza vaccination: a critical review. Newall AT; Jit M; Beutels P Pharmacoeconomics; 2012 Aug; 30(8):647-60. PubMed ID: 22788257 [TBL] [Abstract][Full Text] [Related]
16. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Nichol KL Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of influenza vaccination of healthy children. Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945 [TBL] [Abstract][Full Text] [Related]
18. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea. Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078 [TBL] [Abstract][Full Text] [Related]
19. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. Crépey P; Redondo E; Díez-Domingo J; Ortiz de Lejarazu R; Martinón-Torres F; Gil de Miguel Á; López-Belmonte JL; Alvarez FP; Bricout H; Solozabal M PLoS One; 2020; 15(5):e0233526. PubMed ID: 32437476 [TBL] [Abstract][Full Text] [Related]
20. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children. Falcón-Lezama JA; Saucedo-Martínez R; Betancourt-Cravioto M; Alfaro-Cortes MM; Bahena-González RI; Tapia-Conyer R BMC Infect Dis; 2020 Mar; 20(1):240. PubMed ID: 32197591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]